|Day Low/High||135.05 / 139.37|
|52 Wk Low/High||92.44 / 143.22|
Large-cap healthcare stocks, especially those in the medical technology sector, are one of the biggest losers in the recent market selloff.
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp has taken over the #54 spot from Snap-On, Inc. , according to ETF Channel.
Don't worry about missing anything, we haven't solved the bond conundrum and the evidence says we get to 3% with selloffs on the way.
The 'winning formula' for this year focuses on growth, size and foreign stocks, Jefferies says.
Jim Cramer is bullish on Marvell Technology, Albemarle, Dominion Energy, Best Buy, Houlihan Lokey.
Jim Cramer explains why some retailers are doing so well and how investors can take advantage of the opportunities.
Company Also Enters Into Accelerated Share Repurchase Agreement
Lose the cynicism or you might miss the move. Jim Cramer outlines the reasons for these gains and why investors need to watch them.
The Health Care SPDR ETF (XLV) was rising nearly 1% in afternoon trading on Tuesday, boosted in part, by solid results from medical equipment company Medtronic.
Jim Cramer is bullish on Ollie's Bargain Outlet, Burlington Stores, Blackstone Group, and UnitedHealth Group.
Jim Cramer says the world's been starved for growth for ages, so suspend your disbelief and don't miss out on this economic opportunity.
Lower costs with transcatheter valve driven by shorter lengths of stay, simpler procedures, fewer hospitalizations and rehab days
Several firms reported both top and bottom line third-quarter misses, as the three major U.S. averages remain in the red on Wednesday.
These are the 12 best investment selections from Fundstrat that may provide investors with 'timely' long-term potential.
Jim Cramer is bullish on Edwards Lifesciences, AeroVironment, Oshkosh Truck, Albemarle and more.
Jim Cramer says that with the exception of the department stores and the oils, a case can be made for almost anything in this market.
Mike Mussallem, chairman and CEO of Edwards Lifesciences, tells Jim Cramer about his company's heart-valve advancements.
Jim Cramer says do your homework, be informed and don't let the wise guys trip you up with their warnings about 'single-stock risk.'
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.